Shopping Cart
- Remove All
Your shopping cart is currently empty
Volagidemab (AMG-477) is a glucagon receptor (GCGR) antagonist and monoclonal antibody for the study of endocrine and metabolic diseases such as type 1 diabetes (T1D) and hypoglycemia.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $247 | In Stock | |
| 5 mg | $645 | In Stock | |
| 10 mg | $986 | In Stock | |
| 25 mg | $1,490 | In Stock | |
| 50 mg | $1,970 | In Stock |
| Description | Volagidemab (AMG-477) is a glucagon receptor (GCGR) antagonist and monoclonal antibody for the study of endocrine and metabolic diseases such as type 1 diabetes (T1D) and hypoglycemia. |
| In vivo | Subcutaneous injection of 5 mg/kg Volagidemab suppresses the phenotype of type 1 diabetes in a mouse model of tetracycline-induced diabetes. [2] |
| Synonyms | REMD-477, REMD477, AMG-477, AMG477 |
| Cas No. | 1233956-13-2 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.